Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...

By Ludwig Burger and Ariane Luthi (Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a ...

Novartis (NVS) has sealed a $3.1 billion deal to acquire clinical-stage biopharmaceutical company Anthos Therapeutics. The ...

The global chemical maker Bayer is backing an expanded effort to shield itself from lawsuits alleging its popular weedkiller ...

Among the notable campaigns for Feb. 7: more Super Bowl spots along with new campaigns for Bayer, Johnnie Walker, On and PETA ...

"Don’t be an opportunity killer. Clients and colleagues alike are looking for people who can help them solve problems—and ...

Dow has begun cutting around 1500 jobs across its global operations as part of a larger plan to save $1 billion (£800 million ...

U.S. agrichemicals firm Corteva posted a smaller fourth-quarter loss on Wednesday, helped by strong sales volumes. Crop ...

Fourth quarter results benefited from 7 percent sales growth and continued cost favorability; Company reported a strong year of cash generation with over $1 billion ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Crisil Coalition Greenwich today announced the 2025 Best Bank and Share Leader award winners. Over 60 banks were recognized ...